Hologic Inc is a global leader in women's health, dedicated to advancing the health and well-being of women through innovative medical technologies. The company's mission focuses on providing high-quality diagnostic and surgical solutions, particularly in the areas of breast health, gynecological health, and skeletal health. Hologic Inc employs a strategy centered on research and development to drive innovation and expand its product offerings. Through its commitment to improving patient outcomes and enhancing healthcare efficiency, Hologic Inc operates in various markets worldwide, delivering cutting-edge solutions that empower healthcare providers and improve the lives of women.

HOLOGIC INC

Hologic, Inc. has recently reported its first-quarter earnings for fiscal 2025, announcing an adjusted earnings per share (EPS) of $1.03. This figure surpasses the Zacks Consensus Estimate of $1.02 and reflects a year-over-year increase from $0.98, highlighting the company's growth trajectory despite market challenges.

Hologic Reports Strong Q1 Earnings of $1.03, Surpassing Estimates but Faces Downgraded Revenue Guidance